Your browser doesn't support javascript.
loading
Outcomes in refractory diffuse large B-cell lymphoma: results from a multicenter real-world study in China.
Wang, Shuo; Wang, Li; Hu, Jianda; Qian, Wenbin; Zhang, Xi; Hu, Yu; Zhu, Qi; Chen, Bobin; Wu, Depei; Chang, Chung-Chou H; Xu, Pengpeng; Zheng, Xiaoyun; Wei, Juying; Liu, Yao; Cui, Guohui; Tang, Yong; Ma, Yan; Huang, Haiwen; Yi, Hongmei; Zhao, Weili.
Afiliação
  • Wang S; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P. R. China.
  • Wang L; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P. R. China.
  • Hu J; Chinese-French Research Center in Living Science and Genomics, Laboratory of Molecular Pathology, Shanghai, 200025, P. R. China.
  • Qian W; Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, P. R. China.
  • Zhang X; The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, Zhejiang, 310003, P. R. China.
  • Hu Y; Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, P. R. China.
  • Zhu Q; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, P. R. China.
  • Chen B; Shanghai Ninth People's Hospital, Shanghai, 200011, P. R. China.
  • Wu D; Huashan Hospital Affiliated with Fudan University, Shanghai, 200040, P. R. China.
  • Chang CH; Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, P. R. China.
  • Xu P; Department of Biostatistics, Graduate School of Public Health, University of Pittsburgh, Pittsburgh, Pennsylvania, 15213, United States of America.
  • Zheng X; Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Rui Jin Hospital Affiliated to Shanghai Jiao Tong University School of Medicine, Shanghai, 200025, P. R. China.
  • Wei J; Chinese-French Research Center in Living Science and Genomics, Laboratory of Molecular Pathology, Shanghai, 200025, P. R. China.
  • Liu Y; Fujian Institute of Hematology, Fujian Medical University Union Hospital, Fuzhou, Fujian, 350001, P. R. China.
  • Cui G; The First Affiliated Hospital of Medical School of Zhejiang University, Hangzhou, Zhejiang, 310003, P. R. China.
  • Tang Y; Department of Hematology, Xinqiao Hospital, Army Medical University, Chongqing, 400037, P. R. China.
  • Ma Y; Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei, 430022, P. R. China.
  • Huang H; Shanghai Ninth People's Hospital, Shanghai, 200011, P. R. China.
  • Yi H; Huashan Hospital Affiliated with Fudan University, Shanghai, 200040, P. R. China.
  • Zhao W; Jiangsu Institute of Hematology, Institute of Blood and Marrow Transplantation, the First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, 215006, P. R. China.
Cancer Commun (Lond) ; 41(3): 229-239, 2021 03.
Article em En | MEDLINE | ID: mdl-33482051

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Commun (Lond) Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Linfoma Difuso de Grandes Células B / Recidiva Local de Neoplasia Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Cancer Commun (Lond) Ano de publicação: 2021 Tipo de documento: Article País de publicação: Estados Unidos